Drugs / Follitropin beta injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00598208 Comparator | May 2003 → Mar 2004 | — | Organon and Co | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Follitropin beta injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00598208 ↗ |
| Modality | Protein / enzyme biologic | “daily injections of 150 IU recombinant follicle-stimulating hormone (rFSH)” PMID 18684735 ↗ Aug 2008 |
| Route | Subcutaneous | “fixed daily dose of 150 IU Puregon® SC was administered” NCT00598208 ↗ |